Browsing by Author Bock, H.L.

Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
2006A rotavirus vaccine for infants: The Asian experiencePhua, K.B.; Emmanuel, S.C.; Goh, P.; Quak, S.H. ; Lee, B.W. ; Han, H.H.; Bock, H.L.; Ward, R.L.; Bernstein, D.I.; De, Vos B.
2006A short report on highlights of worldwide development of RIX4414: A Singaporean experiencePhua, K.B.; Quak, S.H. ; Emmanuel, S.; Goh, P.S.C.; Han, H.H.; Bock, H.L.; Hardt, K.; De, Vos B.
Aug-2009An update of paediatric intussusception incidence in Singapore: 1997-2007, 11 Years of intussusception surveillanceTan, N.; Teoh, Y.-L.; Phua, K.-B.; Quak, S.-H. ; Lee, B.-W. ; Teo, H.J.E.L.; Jacobsen, A.; Boudville, I.C.; Ng, T.; Verstraeten, T.; Bock, H.L.
2003Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infantsShek, L.P.C. ; Khor, E.S.H.; Tan, G.H.; Low, K.T.; Ong, D.; Roy, J. ; Lee, B.W. ; Han, H.H.; Bock, H.L.
1-Sep-2005Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infantsPhua, K.B.; Quak, S.H. ; Lee, B.W. ; Emmanuel, S.C.; Goh, P.; Han, H.H.; De Vos, B.; Bock, H.L.
2005Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infantsPhua, K.B.; Quak, S.H. ; Lee, B.W. ; Emmanuel, S.C.; Goh, P.; Han, H.H.; Bock, H.L.; De, Vos B.
Apr-2006Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adultsChan, S.H. ; Tan, P.T.N.; Han, H.H.; Bock, H.L.
Jul-2008Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus Influenzae type b combination vaccine in a placebo-controlled rotavirus vaccine studyKong, B.P.; Seng, H.Q. ; Fong, S.L.; Goh, P.; Yee, L.T.; Datta, S.K.; Han, H.H.; Bock, H.L.
2009Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled studyPhua, K.B.; Lim, F.S.; Teoh, Y.L.; Lau, Y.L.; Nelson, E.A.S.; Huang, L.M.; Quak, S.H. ; Lee, B.W.; Tang, H.; Boudville, I.; Oostvogels, L.C.; Suryakiran, P.V.; Smolenov, I.V.; Han, H.H.; Bock, H.L.
2008Vaccination greatly reduces disease, disability, death and inequity worldwideAndre, F.E.; Booy, R.; Bock, H.L.; Datta, S.K.; Clemens, J.; John, T.J.; Lee, B.W. ; Lolekha, S.; Peltola, H.; Ruff, T.A.; Santosham, M.; Schmitt, H.J.